These findings indicate region-level opportunities to improve the receipt of pre-treatment medical oncology consultation and NAC for women with TN and HER2+ breast cancer, and they contribute to a growing body of literature on the influence of geography in breast cancer care systems. The gene discussed is ERBB2; the disease is breast cancer.